REG - Elementis PLC - Commencement of share buyback programme

ElementisAnnouncement

Wed 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260603:nRSC7308Ga&default-theme=true

RNS Number : 7308G  Elementis PLC  03 June 2026

3 June 2026

 

Elementis plc

 

Commencement of share buyback programme

 

Further to the announcement of 2 June 2026, Elementis plc ("Elementis" or the
"Company"), announces that from today it will commence a programme to purchase
up to approximately £25m (equivalent to approximately $35m) of the Company's
ordinary shares of 5 pence each (the "Ordinary Shares") (the "Programme") by
no later than 28 February 2027.

The purpose of the Programme is to reduce the Company's share capital and
accordingly the Company intends to cancel the majority of shares repurchased,
with a proportion retained in treasury to meet obligations under the Company's
employee share scheme. Any purchases will be conducted in compliance with the
relevant conditions for trading, restrictions regarding time and volume,
disclosure and reporting obligations, and price conditions. The Company
confirms that it currently has no unpublished Inside Information.

The Programme will be conducted by the Company in accordance with and under
the terms of the general authority granted by the Company's shareholders at
the Company's Annual General Meeting on 29 April 2026 which authority will
expire at the end of the next Annual General Meeting of the Company in 2027
or, if earlier, 1 July 2027 ("2026 Authority"). The Company has appointed
Rothschild & Co Global Markets Solutions Limited ("Rothschild & Co")
to manage the Programme and has issued an irrevocable instruction to
Rothschild & Co to continue to manage the Programme, within pre-set
parameters, during any closed period. This appointment will continue until 28
February 2027 (unless terminated earlier in accordance with its terms),
subject to automatic extension in certain circumstances. The Programme will be
carried out on the London Stock Exchange and other trading venues(( 1 )) and
executed within the parameters of the Market Abuse Regulation 596/2014/EU and
the Commission Delegated Regulation 2016/1052/EU (as each forms part of
domestic law under the European Union (Withdrawal) Act 2018, including where
relevant pursuant to the Market Abuse (Amendment) (EU Exit) Regulations 2019)
and Chapter 9 of the UK Listing Rules of the Financial Conduct Authority.
Transactions undertaken under the Programme will be disclosed by way of a
Regulatory Information Service announcement on a weekly basis.

The aggregate maximum consideration payable by the Company in respect of the
purchase of shares under the Programme up to 28 February 2027 is up to
approximately £25m (equivalent to approximately $35m). The maximum number of
shares that may be purchased under the Programme is 56,931,567 (being the
number of shares able to be purchased under the 2026 Authority).

 

Enquiries

 Investors:                                                Zeeshan Maqbool, Elementis plc         Tel: +44 (0) 7553 340 380
 Press:                                                    Martin Robinson, Giles Kernick, Teneo  Tel: +44 (0) 20 7353 4200

 

 

About Elementis

Elementis is a global specialty chemicals company listed on the London Stock
Exchange. The Group employs c.1,000 across 18 global locations. As recognised
innovation leaders with deep expertise in rheology (the science of flow), and
formulation solutions, we develop distinctive solutions and products to
improve performance, achieve smoother production, and enhance sustainability
credentials for customers across a range of industries. The Group also owns
and operates one of the largest known commercial high-quality hectorite mines
in the world. Hectorite is a special, high-purity clay mineral rich in
magnesium and lithium, known for its ability to control viscosity, stabilise
formulations, and deliver smooth, consistent textures that make it ideal for
clean-label, high-performance formulations.

Elementis is composed of two focused, high-margin businesses: Personal Care
and Coatings. The Personal Care business manufactures natural and synthetic
rheology modifiers to deliver premium product performance for personal care
applications in skin care and cosmetics, as well as active ingredients for
antiperspirants. Within Coatings, Elementis develops and manufactures
rheology modifiers and premium performance additives for decorative and
industrial paints and coatings. The Coatings business also includes our Energy
and Adhesives, Sealants and Construction additives businesses.

( 1 ) Turquoise, Chi-X Europe and BATS Trading Europe.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCAKBBNOBKDFAK



            Copyright 2019 Regulatory News Service, all rights reserved